jessica
Dorsal root ganglion stimulation evokes motor responses in patients with complete...
Bilateral L4 dorsal root ganglion (DRG) stimulation has been shown to evoke strong and reproducible motor responses in the upper leg in patients with...
New study tests “first-of-its-kind” EEG device
Methodist Le Bonheur Healthcare (MLH) is the first hospital system globally to participate in a landmark study using a first-of-its-kind EEG device.
A press release...
RapidAI receives FDA clearance of Rapid LVO for identification of suspected...
RapidAI has announced that Rapid LVO has received US Food and Drug Administration (FDA) clearance for detecting suspected large vessel occlusions (LVOs).
Rapid LVO helps...
Wallaby Medical raises funds to accelerate device development for stroke treatment
Wallaby Medical announced it has recently closed a series B+ financing round worth more than US$20 million. The company focuses on developing and commercialising...
Medtronic announces US launch of its InterStim Micro neurostimulator
Medtronic has announced that its recently US Food and Drug Administration (FDA)-approved InterStim Micro neurostimulator for sacral neuromodulation (SNM) therapy is now available in...
News from SNIS: New study finds racial disparities in acute stroke...
A new study has found several racial disparities after mechanical thrombectomy for stroke with respect to post-procedure management and outcomes. Vineeth Thirunavu of Northwestern...
News from SNIS: Bridging therapy independently predicts haemorrhagic complications in atrial...
Exposure to bridging therapy independently predicts haemorrhagic complications—without improving functional outcomes—in patients with atrial fibrillation (AF) associated stroke. The findings from this retrospective, registry...
LIVE from SNIS: Endovascular brain-computer interface improves function in paralysed patient
According to late-breaking data presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting, a wireless endovascular brain–computer interface (BCI) “may improve capacity to perform activities in daily living...
Richard P Klucznik
Richard P Klucznik currently serves as the president of the Society of NeuroInterventional Surgery (SNIS) and the director of interventional neuroradiology at The Methodist...
LIVE from SNIS: 51% of neurointerventional non-physician staff report burnout
A survey of US neurointerventional non-physician procedural staff demonstrates a self-reported burnout prevalence of 51%. According to Patrick Brown of Wake Forest Baptist University...
FDA clears SOMATOM On.site from Siemens Healthineers for CT exams at...
The US Food and Drug Administration (FDA) has cleared the SOMATOM On.site, a mobile head computed tomography (CT) scanner from Siemens Healthineers that enables...
Stryker’s Neuroform Atlas stent approved to treat aneurysms of the posterior...
Stryker announced that it has received US Food and Drug Administration (FDA) approval for an expanded indication of its Neuroform Atlas stent system as...
LIVE from SNIS: The stroke trials you need to know about
From acute interventions to endovascular therapy indication expansion, Sunil Sheth from McGovern Medical School at UTHealth, Houston, USA, kick-started the Society of NeuroInterventional Surgery’s...
LIVE from SNIS: New study validates use of RACE scale for...
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting (4–7 August, virtual meeting) serves as the first prospective validation...
LIVE from SNIS: Treatment advancements have reduced mortality rates from unruptured...
Mortality rates after treatment of unruptured intracranial aneurysms have substantially decreased in the past decade, according to new findings presented at the Society of...
Cerus Endovascular and Balt enter strategic distribution agreement for devices treating...
Cerus Endovascular and AB Medica, a subsidiary of Balt, has announced that they have entered into a strategic distribution agreement providing AB Medica with...
Axonics announces two-year results from its ARTISAN-SNM study
Two-year results of Axonics’ ARTISAN-sacral neuromodulation (SNM) study demonstrate that patients implanted with the r-SNM system continue to receive clinically meaningful and statistically significant...
New study shows significant positive impact of vagus nerve stimulation therapy...
Adding vagus nerve stimulation (VNS) therapy to treatment as usual has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD). In...
Novel tandem stent thrombectomy technique a “safe and effective” rescue treatment
A novel tandem stent thrombectomy technique “seems to be a safe and effective” rescue treatment for acute large vessel occlusion (LVO) that is resistant...
CerusEndo MC 021 microcatheter wins CE mark
Cerus Endovascular has announced that it has received CE mark approval for its CerusEndo MC 021 microcatheter, designed to allow physicians to access tortuous...
Synchron secures funding to advance commercialisation of Stentrode
Synchron has been awarded nearly AUD$1M ($990,000) in funding from the Medical Research Future Fund (MRFF), through MTPConnect, the Australian Government’s BioMedTech Horizons (BMTH)...
Rapid Medical’s Tigertriever XL receives CE mark approval
Rapid Medical has announced CE mark approval for Tigertriever XL stentriever. The company noted that the first patients have been treated successfully with the...
Brilinta significantly reduced the rate of the composite of stroke and...
Results from the positive phase III THALES trial showed AstraZeneca’s Brilinta (ticagrelor) 90mg used twice daily and taken with daily aspirin for 30 days,...
FDA approves Abbott’s iOS-compatible app for the management of chronic pain...
Abbott announces it has received approval from the US Food and Drug Administration (FDA) for the use of its Patient Controller app on compatible...
NeuroNews Issue 38 – US Edition
Highlights:
COVID-19 causes "widespread disruption" to neuroendovascular research around the globe
Stroke risk found higher in patients with COVID-19 than influenza
Thrombectomy proved efficacious...
NeuroNews Issue 38
Highlights:
COVID-19 causes "widespread disruption" to neuroendovascular research around the globe
Stroke risk found higher in patients with COVID-19 than influenza
Thrombectomy proved efficacious...
COVID-19 causes “widespread disruption” to neuroendovascular research around the globe
“Widespread disruption of neuroendovascular trials occurred because of COVID-19,” conclude the investigators of a survey-based study examining the impact of the pandemic. Now, as...
Asleep surgery improves the therapeutic window for deep brain stimulation
Evidence in support of the motion that asleep surgery improves the therapeutic window for deep brain stimulation (DBS) when compared to awake surgery, has...
Stroke risk higher in patients with COVID-19 than influenza
A higher rate of stroke has been reported in adults with COVID-19 compared to a cohort of patients with influenza. A retrospective study published...
Up to 13% of patients could have their spinal cord stimulator...
According to a study published in Neuromodulation, five years after implantation, spinal cord stimulators have been explanted in 13.5% of patients. Furthermore, about 10%...
“Stoicism kills”: A concerning trend is causing preventable stroke deaths
A concerning new trend has been revealed by the Stroke Association. The charity states that the most at-risk groups are least likely to call...
Balt receives CE mark for its Silk Vista flow diverter
Balt has received CE mark approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms, in turn enabling commercialisation...
Soterix wins IDE for depression treatment trial
Soterix Medical has announced that it received US Food and Drug Administration (FDA) investigational device exemption (IDE) to launch a trial of its non-invasive transcranial...
RECOVER trial design evaluating vagus nerve stimulation for treatment-resistant depression published
LivaNova announces a publication in Contemporary Clinical Trials, which details the design for a prospective, multicentre, randomised controlled blinded trial demonstrating the safety and...
Rapid ASPECTS receives CADx clearance from the FDA
RapidAI has announced that Rapid ASPECTS has received US Food and Drug Administration (FDA) clearance as the first neuroimaging analysis device in the CADx (computer-assisted...
Burst spinal cord stimulation improves psychosocial outcomes and reduces opioid usage...
A study investigating chronic pain sufferers treated with burst spinal cord stimulation (B-SCS) has concluded that improvements were observed among all psychological measures at...
Jesse Dawson
“It is an amazing time to work in stroke medicine,” Jesse Dawson tells NeuroNews. Looking back at his career, he discusses the field’s biggest...
Axonics receives FDA approval for 3T full-body MRI scans
Axonics, a company that has developed and is commercialising novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, has...
First clinical study using patient-specific brain aneurysm models for pre-procedural rehearsals...
The findings of the first clinical study to use the EVIAS (Biomodex) 3D printing models to plan aneurysm treatment using endovascular robotics and novel...
FDA approves Percept PC neurostimulator with BrainSense technology
Medtronic has announced it received US Food and Drug Administration (FDA) approval for the Percept PC deep brain stimulation (DBS) system. BrainSense technology makes...
Mainstay Medical announces FDA approval of ReActiv8 neurostimulation system for chronic...
Mainstay Medical has announced that the US Food and Drug Administration (FDA) has approved the company’s premarket approval (PMA) application for ReActiv8, its implantable...
Thrombectomy proved efficacious in Latin America as the final results of...
After receiving a standing ovation when presented at the European Stroke Organisation Conference (ESOC; 22–24 May, Milan, Italy) last year, the final results of...
CereVasc gains financing to support eShunt system to treat hydrocephalus
CereVasc, a company focused on the treatment of patients with hydrocephalus, announced the closing of an expanded Series A financing that raised US$43.9 million....
MIVI Neuroscience receives IDE approval to study the Q aspiration catheter
MIVI Neuroscience has announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption for the initiation of a...
Transradial access may be safer than transfemoral access for flow diversion...
Transradial, as opposed to transfemoral access, may be a safer approach for flow diversion procedures to treat cerebral aneurysms at a wide range of locations. This conclusion was reached...
FDA approval for Axonics’ wireless patient Remote Control with SmartMRI technology
Axonics, a company that has developed implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, has announced US Food and...
phenox announces European launch of its new thrombectomy devices
phenox has announced the full European launch of the pRESET 5–40 and pRESET LUX 4–20 thrombectomy devices after receiving CE mark approval last year....
Incidence of stroke due to COVID-19 lower than previously reported, study...
A recently published study has shown fewer people than previously reported have had strokes as a result of COVID-19; however, strokes that accompany the...
New study shows significant positive impact of vagus nerve stimulation therapy...
Adding vagus nerve stimulation (VNS) therapy to treatment as usual (TAU) has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD)....
Endovascular therapy fails to outperform best medical management in basilar artery...
Final results of the Basilar artery international cooperation study (BASICS) have been reported by Wouter J Schonewille (University Medical Centre Utrecht, Utrecht, the Netherlands)...
Routine use of fluoxetine after acute stroke not recommended
The final results of EFFECTS (Efficacy of fluoxetine: A randomised controlled trial in stroke) have been presented by Erik Lundström (Uppsala University, Uppsala, Sweden)...
Decision-making in intrathecal drug delivery devices “life-threatening” amid COVID-19
Amid the COVID-19 pandemic, the need to prevent the spread of disease and manage critical hospital resources has never been more critical. In a...
Balt receives IDE approval to begin the STEM trial
Balt has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin the Squid trial for the embolisation of the middle meningeal...
Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...
An article accepted into the journal Neuromodulation has concluded that, based on two case reports, non-invasive vagus nerve stimulation (nVNS) might provide clinical benefits...
Direct mechanical thrombectomy alone deemed non-inferior to its combination with alteplase
Investigators of the DIRECT-MT trial, who evaluated Chinese patients with acute ischaemic stroke from large-vessel occlusion, concluded that endovascular thrombectomy alone was non-inferior in...
COVID-19 patients are “hypercoagulable and at an increased risk for stroke”
The association between COVID-19 and the increased incidence of stroke continues to grow. Situated within the pandemic’s epicentre, Kurt Yaeger and J Mocco, neurosurgeons...
NeuroNews Issue 37
Highlights:
NeuroNews reports on a webinar hosted by SNIS that brought together physicians from Italy, China and the USA, each of whom detailed the...
NeuroNews Issue 37
Highlights:
NeuroNews reports on a webinar hosted by SNIS that brought together physicians from Italy, China and the USA, each detailing the lessons they...
Educational curriculum for spinal cord stimulation developed to fill “unmet need”
A spinal cord stimulation (SCS) training curriculum has been developed by a multidisciplinary taskforce of the North American Neuromodulation Society’s (NANS) education committee. It...
phenox launches p64 MW Flow modulation device with HPC coating technology
phenox has announced the European launch of the new p64 MW Flow modulation device, intended for the treatment of intracranial aneurysms. The device received...
Cerus Endovascular’s 021 Contour neurovascular system approved in Europe
Cerus Endovascular has received CE Mark approval for its 0.021-inch Contour neurovascular system, compatible with smaller commercially available 021 microcatheters for the treatment of...
Large-vessel stroke: A feature of COVID-19 in the young
A case series of large-vessel stroke in patients younger than 50 years of age has been published in The New England Journal of Medicine....
Telemedicine in neurointervention set to last beyond the hype
“Telehealth is finally upon us. As someone who has been practicing in this world for several years, I was always waiting for an inflection...
Cerus Endovascular receives CE mark for its Neqstent Coil Assisted Flow...
Cerus Endovascular has announced that it has received CE mark approval for its Neqstent Coil Assisted Flow Diverter device. The flow diverter is designed...
EXTEND-IA TNK Part 2 trial finds no benefit of higher tenecteplase...
With the original trial demonstrating a higher incidence of substantial reperfusion with tenecteplase compared with alteplase prior to endovascular therapy, EXTEND-IA TNK Part 2...
Stroke care in London as pressure on NHS rises amid COVID-19
Following the announcement that the UK will remain on lockdown for the foreseeable future, NeuroNews speaks to Shahram Derakhshani about the impact of COVID-19...
The role of neurosurgeons during COVID-19
COVID-19 represents a global challenge that has exposed the USA’s fragmented public healthcare system, writes Demetrius Lopes. Here, he details Chicago’s action plan in...
Axonics wins FDA approval for its next-generation implantable neurostimulator
Axonics has announced the US Food and Drug Administration (FDA) approval of its next-generation rechargeable implantable neurostimulator for its r-SNM system under a premarket approval...
COVID-19: Lessons learnt from Italy, China and the USA
A webinar hosted by the Society of NeuroInterventional Surgery (SNIS) on 2 April brought together neurointerventionalists and endovascular neurosurgeons from Italy, China, and the...
Enrolment completed early for Rapid Medical’s TIGER study for thrombectomy device
Rapid Medical has announced that it has completed enrolment in the TIGER (Treatment with Intent to generate reperfusion) study ahead of the planned scheduled....
New York City in the age of COVID-19: A Neuroendovascular experience
Amid the chaos of the pandemic, it is becoming increasingly difficult, "if not impossible", to care both critically-ill COVID-19 sufferers and non-COVID patients simultaneously,...
Cervical non-invasive vagus nerve stimulation effectively relieves pain in migraine sufferers
A recent meta-analysis demonstrated that cervical non-invasive vagus nerve stimulation (nVNS) is a safe and effective method for acute pain relief in migraine and...
SNIS releases recommendations for emergent neurointerventional patients during COVID-19
The Society of NeuroInterventional Surgery (SNIS) has published a set of recommendations for the care of emergent neurointerventional patients during the COVID-19 pandemic.
“Acute...
Selective endovascular cooling with TwinFlo catheter shows promise for neuroprotection in...
Ron Solar (ThermopeutiX, San Diego, USA) and colleagues report in EuroIntervention that the TwinFlo catheter (ThermopeutiX), in pigs, was associated with rapid, selective, deep...
Diffusion Pharmaceuticals anticipates coronavirus will slow enrolment in its ambulance-based stroke...
Diffusion Pharmaceuticals has announced that it expect delays in enrolment in the company’s ambulance-based PHAST-TSC phase 2 clinical trial in acute stroke due to...
Novel intermittent dosing burst spinal cord stimulation deemed safe and efficacious...
A novel intermittent dosing burst paradigm in spinal cord stimulation (SCS) has effectively relieved pain in patients with chronic intractable pain. Authors Timothy Deer,...
Artio Medical announces interim study results highlighting aneurysm occlusion device
Artio Medical has announced the recent presentation of interim nonclinical study results at the ABC-WIN Seminar in Val d'Isere, France. Presented by Blaise Baxter,...
LivaNova collaborates with Verily to fuel research into vagus nerve stimulation...
LivaNova has announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within its RECOVER clinical study, which is evaluating...
ISC News: Trend toward benefit in using blood-clotting agent to treat...
Treatment with tranexamic acid, a common medication that reduces bleeding, has led to a non-statistically significant reduction in intracerebral haemorrhage (ICH) growth, both in...
Cerus Endovascular receives FDA Approval for its first microcatheter
Cerus Endovascular receives US FDA approval for its first microcatheter. The 021 microcatheter will be offered with three different distal configurations, and commercial sales...
ISC News: AUGUSTUS secondary analysis confirms safety of blood thinning agent
Treatment with the blood thinner apixaban was associated with a lower risk of bleeding, death and hospitalisation compared with warfarin, regardless of history of...
ISC News: Non-inferiority for direct mechanical thrombectomy “could not be proven”
Skipping IV thrombolysis and using mechanical clot removal alone for stroke was not shown to be non-inferior compared to the combination of both treatments,...
Live from ISC: Fast treatment via mobile stroke unit found to...
Treating stroke patients in specialised ambulances speeds treatment and reduces patients’ disability, according to late-breaking science presented at the International Stroke Conference (ISC; 19–21...
Brain stents are safe and effective for reducing recurrent stroke risk,...
A brain stent appears safe and effective for reducing the risk of recurrent stroke in patients with cholesterol-clogged brain arteries, according to late-breaking data...
Live from ISC: Wearable brain stimulation could safely improve motor function...
A new, non-invasive wearable magnetic brain stimulation device to improve recovery for stroke survivors has been deemed safe and effective. David Chiu, director of...
Live from ISC: Study finds endovascular therapy access within 15 minutes...
Current direct endovascular therapy access for acute ischaemic stroke within 15 minutes is limited to one-fifth of the US population, concludes a recent...
Viz.ai adds new capabilities to its AI stroke platform
Viz.ai has launched the next generation of its synchronized care platform for stroke. Viz.ai incorporates cutting edge artificial intelligence with HIPAA-compliant communication to allow...
ISC News: Blacks, Hispanics of Caribbean descent have higher stroke risk...
Both Blacks and Hispanics of Caribbean descent living in Northern Manhattan have a significantly higher risk of stroke than their non-Hispanic, white neighbours, according...
Cerus Endovascular receives CE mark approval for its Contour Neurovascular System...
Cerus Endovascular has received CE mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. The system incorporates...
Portable MRIs bring diagnostics to stroke patients’ bedside
A portable, low-field magnetic resonance imaging (MRI) system may become a safe and practical way to get accurate brain images at a patient’s bedside,...
New study finds high responder rates for ECAP-controlled, closed-loop spinal cord...
A randomised, double-blind trial finds ECAP-controlled closed-loop spinal cord stimulation (SCS) statistically superior for the treatment of chronic pain, compared to open-loop stimulation. At...
Jason Pope
Jason Pope is the president and CEO of Evolve Restorative Center in Santa Rosa, USA, and serves as president of the Californian Society of...
News from NANS: 10kHz safe and effective for treating painful diabetic...
A multicentre study across 18 centres finds 10kHz safe and effective for the treatment of painful diabetic neuropathy. Sensory improvements were observed in many...
NeuroNews Issue 36 – US Edition
Highlights:
NeuroNews exclusively interviews Vitor Mendes Pereira (Toronto, Canada) who has recently performed the world’s first-in-human robotic-assisted brain surgery
Demetrius Lopes (Chicago, USA) discusses...
NeuroNews Issue 36
Highlights:
NeuroNews exclusively interviews Vitor Mendes Pereira (Toronto, Canada) who has recently performed the world’s first-in-human robotic-assisted brain surgery
Demetrius Lopes (Chicago, USA) discusses...
Quick and easy imaging interpretation for stroke therapy: The promise of...
Stroke treatment is time-sensitive. Every minute counts. Every delay in decision-making affects patient outcome. Given this, JM Ospel and colleagues from the University of...
FDA approval of Axonics’ enhanced neurostimulator programmer
Axonics announces US Food and Drug Administration (FDA) approval of an enhanced, second-generation programmer for its r-SNM system under a premarket approval (PMA) application...
Stratus Medical completes private placement financing and acquisition of the NimbusRF
Stratus Medical, a new company created to focus on advancing radiofrequency (RF) ablation treatment for chronic pain, has announced that it completed a private...
Blood pressure reduction inversely associated with poor outcome after successful reperfusion
A study investigating the relationship between systolic blood pressure (BP) reduction and outcome of mechanical thrombectomy has shown that systolic BP, in the first...
News from NANS: First long-term vagus nerve stimulation implant in mice
Data showing the effective use of a long-term vagus nerve implant in mice have been presented at the North American Neuromodulation Society’s (NANS) annual...
Centres of excellence for neuromodulation: A critical proposal
While recognising that excellence derives from experience, Robert M Levy suggests that the neuromodulation community can better protect the field’s “desire to ensure excellence...
Medtronic launches Efficio software to help clinicians efficiently manage targeted drug...
Medtronic announce the launch of Efficio, a cloud-based data management software for use with the SynchroMed II intrathecal drug delivery system, that will allow...
DTM spinal cord stimulation using Medtronic’s Intellis platform shows superior back...
Three-month results from a large, multicentre randomised controlled trial (RCT) has demonstrated statistically significant (p=0.0009) and superior back pain relief with differential target multiplexed...
Abbott receives expanded indication from FDA for directional DBS to treat...
Abbott has announced it received approval from the US Food and Drug Administration (FDA) for a new, expanded indication for the company's Infinity deep...
News from NANS: BurstDR stimulation reduces negative psychological effects associated with...
New quality of life and functional improvement data from both the BOLD and TRIUMP studies echo the benefits of the Proclaim XR neurostimulation system...
News from NANS: 10kHz spinal cord stimulation deemed safe and effective...
Data from a prospective, multicentre trial examining high-frequency spinal cord stimulation (SCS) at 10kHz for the treatment of chronic pelvic pain supports the safety...
SPRINT peripheral nerve stimulation system demonstrates 12 months of low back...
SPR Therapeutics has announced publication of a prospective case series regarding its SPRINT peripheral nerve stimulation (PNS) system in the treatment of low back...
Use of optical coherence tomography deemed feasible after first-in-human analysis
Results of the first-in-human analysis of acute interactions and healing process after flow diverter implantation using optical coherence tomography (OCT) imaging was presented by...
Medtronic receives CE mark for InterStim Micro Neurostimulator and InterStim SureScan...
Medtronic has announced it has received CE mark for its InterStim Micro neurostimulator and InterStim SureScan MRI leads—clearing the technologies for commercial sale and...
US FDA clears Aidoc’s complete AI stroke package
Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
Self-expanding bioabsorbable flow-diverting stent shows a favourable safety profile
The preliminary safety data of a “self-expanding primarily bioabsorbable flow-diverting” stent has shown to be consistent with a favourable profile in terms of mechanical...
MicroVention’s FRED flow diverter now FDA approved
MicroVention, a US based subsidiary of Terumo and a global neurovascular company announced the US FDA premarket approval (PMA) for the FRED (Flow re-direction...
Medtronic receives CE mark approval for the Percept PC Neurostimulator deep...
Medtronic announces the CE mark for Percept PC neurostimulator. It is the only Deep Brain Stimulation (DBS) system to be launched in the European...
Medtronic acquires Stimgenics, pioneer of Differential Target Multiplexed spinal cord stimulation
Medtronic has acquired Stimgenics, a privately-held company that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM) Spinal...
Intrasaccular aneurysm treatment device receives US FDA PMA approval
MicroVention, a US-based subsidiary of Terumo and a global neurovascular company, announces the US FDA premarket approval (PMA) for the WEB aneurysm embolisation system...
Surface modification: From bench to clinical practice
Demetrius Lopes has been working on the surface modification of stents and flow diverters, given that thromboembolic and antiplatelet-related complications represent the majority of...
Saluda Medical results of US Evoke pivotal study through 12 months...
Saluda Medical has announced The Lancet Neurology journal published results from the US pivotal study demonstrating its Evoke ECAP-controlled, closed-loop spinal cord stimulation (SCS)...
Axonics granted six US patents and allowed three additional patents related...
Axonics has announced that the United States Patent and Trademark Office has issued or allowed Axonics nine US utility patents in 2019, along with...
Aleva Neurotherapeutics receives CE mark for its directSTIM directional Deep Brain...
Aleva Neurotherapeutics has announced that it has been awarded the CE mark for its flagship product, the directSTIM Deep Brain Stimulation System. The system...
Imperative Care announces US$85 million Series C financing for stroke treatments
Imperative Care has completed the initial closing of a Series C financing of US$85 million to support the commercial launch of the company’s portfolio,...
Axonics provides survey results from Physician Seminar Series showcasing the recently...
Axonics, a medical technology company that has developed and is commercialising novel implantable Sacral Neuromodulation (SNM) devices for the treatment of bladder and bowel...
First-pass success reduces hospitalisation-related and annual care costs in six European...
The first European study to evaluate the economic impact of first-pass effect (FPE) found that FPE patients not only benefit clinically, they also endorse...
First educational module for neuromodulation ensures field is “future-proof”
The first educational module for neuromodulation, a masters-level e-learning course aimed at nurses and allied healthcare professionals working within the field, received its first...
Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite...
Philips announces the launch of IntelliSpace AI Workflow Suite to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of...
New data demonstrates “unprecedented” efficacy outcomes with the NeuroPace RNS system
NeuroPace has announced that new data from a multicentre, real-world clinical study of the RNS system has demonstrated outcomes never before seen with other...
Philips announces WE-TRUST multicentre clinical trial to assess impact of direct-to-angiosuite...
Philips has announced a major clinical trial to assess the impact of a direct-to-angiosuite workflow on stroke patient outcomes. The study will assess whether...
Pooled analysis finds dorsal root ganglion stimulation “safe and effective” for...
Dorsal root ganglion (DRG) stimulation is a safe and effective therapy for multiple chronic pain disorders, concludes a pooled analysis published in Neuromodulation. The...
Viz.ai launches a range of new AI features
Viz.ai has announced a number of new features at the Society of Vascular and Interventional Neurology (SVIN) annual meeting in Atlanta, USA (20–23 November,...
Although “unperfected”, AI has the potential to accelerate and synchronise stroke...
A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
Axonics announces US Food & Drug Administration approval for its sacral...
Axonics, a medical technology company that has developed and is commercialising novel implantable rechargeable sacral neuromodulation (SNM) devices for the treatment of bladder and...
Brainomix AI software improves stroke treatment rates at Budapest University Hospital
On the 8th of November 2019, during a symposium at the annual meeting of the Hungarian Neuroradiology Society (MNRT) in Mátraháza, Hungary, Bence Gunda...
MR CLEAN II trials are expanding into France
The recent European Society of Minimally Invasive Neurological Therapy (ESMINT; 4–6 September, Nice, France) meeting saw Adriaan C G M van Es of Erasmus...
Over-the-skin electrical stimulation helps provide movement in quadriplegics
Researchers at The Feinstein Institutes for Medical Research used new closed-loop neurostimulation methods and textile-based electrodes to facilitate individual finger movement and grasp force...
World’s first robotic-assisted aneurysm coiling has been performed using Corindus’ CorPath...
The first-in-human robotic-assisted neurovascular intervention has been performed at the Toronto Western Hospital (Toronto, Canada), by a team led by Vitor Mendes Pereira. A...
WFITN 2019: Homogeneous organisation of stroke care across countries is next...
Mario Muto (Naples, Italy), president of WFITN 2019 (World Federation of Interventional and Therapeutic Neuroradiology; 21-24 October; Naples, Italy), talks to BLearning Neuro about challenges in...
WFITN 2019: Vessel wall imaging “has added value for select stroke...
Joanna Schaafsma (Toronto, Canada) talks to BLearning Neuro at WFITN 2019 (World Federation of Interventional and Therapeutic Neuroradiology; 21–24 October; Naples, Italy) about the potential benefits and...
Nevro announce launch of a new medical device for the treatment...
Nevro today announced it has received approval from the US Food and Drug Administration (FDA) for the Senza Omnia spinal cord stimulation (SCS) system....
Axonics announces first commercial US patient implanted with its sacral neuromodulation...
Axonics has announced the first US-based implantation of the Axonics r-SNM system subsequent to its clearance by the US Food & Drug Administration (FDA)...
TSI enrols first 10 patients in its phase 2 ischaemic stroke...
Thrombolytic Science (TSI) has announced progress with 10 patients enrolled in its prospective, randomised, multicentre phase 2 clinical trial, designed to confirm the safety...
Parent vessel-preserving strategies may “eliminate the risk of ischaemic complications associated...
“Parent vessel-preserving strategies cannot be considered inferior to parent vessel occlusion ,” concluded Gopinathan Anil, National University Hospital, Singapore, during his presentation on dissecting...
WFITN 2019: Selective brain cooling could benefit “fast progressing” ischaemic stroke...
Waleed Brinjikji talks to BLearning Neuro at WFITN 2019 (World Federation of Interventional and Therapeutic Neuroradiology; 21–24 October, Naples, Italy) about his presentation on selective brain cooling, a...
Boston Scientific announces CE mark approval of the VERCISE Neural Navigator...
Boston Scientific has announced the CE mark approval of the Vercise Neural Navigator 3 directional deep brain stimulation (DBS) programming software—the first system that...
Perflow Medical receives CE mark approval of Cascade Agile
Perflow Medical has announced they have received CE Mark approval for the Cascade Agile non-occlusive remodelling net (Cascade Agile). Expanding the Cascade product family,...
Imperative Care announces appointment of Brian Armijo as vice president of...
Imperative Care has announced that Brian Armijo has been appointed as vice president of operations. With more than 25 years of manufacturing and operations...
Superior clinical outcomes for endovascular therapy candidates triaged directly to a...
For patients with emergent large vessel occlusion (LVO) eligible for endovascular therapy, prehospital triage to a more distant comprehensive stroke centre (CSC) compared with...
General anaesthesia associated with better clinical outcome compared to procedural sedation...
In a recently published systematic review and meta-analysis, the use of protocol-based general anaesthesia (GA) in acute ischaemic stroke patients undergoing thrombectomy was significantly...
ESMINT 2019: Neuroradiology has seen “dramatic changes” from the early days
Jacques Moret (Paris, France) talks to BLearning Neuro about his presentation titled ‘Past, present and future of neuroradiology’ at ESMINT 2019 (European Society of Minimally Invasive Neurological...
Guerbet signs agreement with icometrix for the distribution of icobrain, an...
Guerbet announces that it has signed an exclusive agreement with icometrix for the distribution in France, Italy and Brazil of icobrain, their Saas (Software...
Insera announces first two stroke patients treated with its cyclical aspiration...
Insera Therapeutics has announced that the first two ischaemic stroke patients have been treated with its flagship cyclic aspiration system, CLEAR. The company received...
Medtronic announces FDA submission for InterStim Micro neurostimulator and SureScanTM MRI...
Medtronic announces it has filed a premarket approval (PMA) supplement with the US Food and Drug Administration (FDA) for approval of its InterStim Micro...
Axonics provides full one-year results from ARTISAN-SNM pivotal study
Axonics announced the presentation of detailed one-year results from its ARTISAN rechargeable sacral neuromodulation (r-SMN) pivotal study at a plenary session at the joint...
FDA approves low-dose spinal cord stimulator for chronic pain
Abbott has received FDA approval for its Proclaim XR recharge-free neurostimulation system for people with chronic pain. A press release reports that the Proclaim...
Axonics announces agreement to supply sacral neuromodulation systems to leading urology...
Axonics has announced that it has entered into an exclusive agreement to supply the Axonics rechargeable sacral neuromodulation (r-SNM) system to Adult Pediatric Urology...
IRRAflow: Needed innovation for neurocritical care
Every two seconds, someone on earth will have a stroke. Every 10 seconds, stroke claims a life. With little respect for age, as a...
NeuroNews Issue 35 – US Edition
Highlights:
NeuroNews exclusively interviews Sheila Martins (Porto Alegre, Brazil) who provides an update on the RESILIENT team’s plan of action following the trial’s positive results,...
NeuroNews Issue 35
Highlights:
NeuroNews exclusively interviews Sheila Martins (Porto Alegre, Brazil) who provides an update on the RESILIENT team's plan of action following the trial's positive...
The Brainstorms Scientific set to host Europe’s first transdisciplinary neuroscience festival
The Brainstorms Scientific are launching the Brainstorms Festival, a two-day business and human-orientated technology event set to take place in Vienna, Austria, on 27–28...
Aidoc releases complete AI package to speed identification and treatment of...
Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...
Phenox announces exclusive distribution agreement with Wallaby Medical for the Avenir...
Phenox announces that it has signed an exclusive distribution agreement with Wallaby Medical for commercialisation of the Avenir Detachable Coil System in the US...
Stimwave launches post-market peripheral neuropathy pain relief randomised controlled trial
In honour of September Pain Awareness Month, Stimwave has announced the launch of a new randomised clinical trial treating painful peripheral neuropathy, known as...
ESMINT 2019: “Vast majority” of people do not expect children to...
Urs Fischer talks to BLearning Neuro at ESMINT 2019 (European Society of Minimally Invasive Neurological Therapy; 4–6 September 2019; Nice, France) about some of the differences regarding...
Turning neuromodulation on its head: Fresh perspectives on interacting with the...
David Putrino has helped innovate a variety of “provocative” technologies within the field of neuromodulation, such as those with the potential to achieve modulatory...
Saluda Medical announces European commercial launch of Evoke, the ECAP-controlled, closed-loop...
Saluda Medical has announced the award of CE mark and the European commercial launch of the Evoke ECAP-controlled, closed-loop spinal cord stimulation (SCS) system...
Patrick Brouwer
Patrick Brouwer speaks to NeuroNews about what he considers to be the most important developments in the neurointerventional field to date. As president of...
Overlook Medical Center participates in study evaluating best medical management for...
Overlook Medical Center’s Atlantic Neuroscience Institute is set to participate in the MIND trial: a prospective, multicentre, randomised controlled trial (RCT) examining the Artemis...
GOLIATH trial wins ESMINT award for best European publication in JNIS
At the recent European Society of Minimally Invasive Neurological Therapy (ESMINT; 4–6 September, Nice, France), the award for the best European publication in the...
Low pain scores following spinal cord stimulation trials found predictive of...
Low pain scores after spinal cord stimulation (SCS) trials are predictive of successful SCS implants with high sensitivity, according to a recent study. The...
While the use of endovascular therapy doubled with the emergence of...
According to Laura Stein and others from the Icahn School of Medicine at Mount Sinai, New York, USA, patients admitted with acute ischaemic stroke...
Axonics announces US FDA approval for its sacral neuromodulation system
Axonics, a medical technology company that has developed and is commercialising a novel implantable rechargeable sacral neuromodulation (SNM) device for the treatment of urinary and...
ESMINT 2019: Drugs to strengthen aneurysm wall will be the future,...
Mika Niemelä (Helsinki, Finland) talks to BLearning Neuro about the ‘Decision making in unruptured aneurysms’ session he chaired at ESMINT 2019 (European Society of Minimally Invasive Neurological Therapy;...
The clinical utility of evoked compound action potentials is echoed by...
New data from both the Evoke and Avalon studies reiterate the importance of objective neurophysiological measures and clinically meaningful outcomes. These studies evaluated the...
Omar Ishrak to step down as Medtronic CEO next year
Omar Ishrak, Medtronic’s chairman and CEO is to retire on 26 April 2020, following the end of the company’s current fiscal year. Also, the...
Advanced engineering improves rates of revascularisation through the first-pass effect
Advertorial
In acute ischaemic stroke, fast and complete recanalisation of the occluded vessel is associated with improved outcomes. While morbidity and mortality in these patients...
Getting it right the first time: Commit to a first-pass effect...
Advertorial
While the treatment paradigm for stroke continues to evolve, even a quick review of the current literature will point to how complete reperfusion...
Combining reperfusion with neuroprotection: Reasons to reappraise the concept
“The main reason to reappraise the concept of neuroprotection in acute stroke is the of effective thrombectomy, which de facto has led to...
Type of stent denotes degree of complete occlusion following stent-assisted coiling...
A study comparing three different stents used during stent-assisted coiling of cerebral aneurysms revealed that the type of stent used affects a patient’s immediate...
Disruptive innovation in neuromodulation: What can we learn from #SocialMedia disrupting...
Twenty-four per cent of doctors are using social media daily to conduct medical research, and 85% of healthcare companies now implement social media marketing,...
The 1st International Distal Thrombectomy Summit called for a need to...
The 1st International Distal Thrombectomy Summit took place in North Italy, 14–15 June, 2019. According to a press release, the purpose of the meeting...
New study finds Abbott’s blood test technology could help detect brain...
Abbott has announced that a new study, published in Lancet Neurology, found that elevated levels of a protein measured with the company's blood test...
Nevro announces completion of patient enrolment in multicentre RCT of high...
Nevro has announced that it has completed patient enrolment in its prospective, multicentre randomised controlled trial (RCT) for the treatment of chronic pain for...
Similar success rates for anatomic and targeted lead placement for spinal...
“Anatomical lead placement is a viable alternative to targeted lead placement for spinal cord stimulation,” concluded Jason E Pope, Evolve Restorative Center, Santa Rosa,...
Three-year outcomes of the Surpass system confirm its safety and efficacy
Three-year outcomes of the Surpass intracranial aneurysm embolisation system pivotal trial to treat large or giant wide neck aneurysm (SCENT trial) confirm the safety...
The burden of a stroke call: 56% of US neurointerventionalists meet...
Fifty-six per cent of US neurointerventionalists meet criteria for burnout. This statistic, presented by Kyle Fargen from Wake Forest Baptist Health in Winston-Salem (USA)...
Thrombectomy fails to find a benefit in the older population with...
A low Alberta stroke program early CT score (ASPECTS) of 4–5 has been deemed the threshold for mechanical thrombectomy, with no benefit elicited in...
The first wireless spinal cord stimulator system elicits a high response...
A study evaluating different waveforms within a wireless spinal cord stimulator (SCS) device (Stimwave) has found high response rates for patients receiving both high...
A robotic future for the neurovascular field is deemed feasible
Does the shift away from open surgical vascular procedures towards percutaneous interventions favour a rise in the use of robotics? Gavin Britz (Houston Methodist...
Flow diverter outcomes are “not device, but technique dependent”
Patrick Brouwer (Stockholm, Sweden) talks to BLearning at SNIS 2019 (22–25 July, Miami, USA) about some of the issues associated with early flow diverters and why there...
South Florida partnership working to save lives using data to guide...
A progressive emergency medical services (EMS)–driven partnership in South Florida (USA) has expedited access to lifesaving care for stroke patients. This groundbreaking effort to...
Perfuze’s Millipede Clot Ingestion System receives breakthrough device designation from FDA
Perfuze, a medical device company developing next-generation catheter-based technology to treat acute ischemic stroke, has been granted breakthrough device designation by the US Food...
SNIS 2019: It is “almost unethical” not to broaden thrombectomy inclusion...
Donald Frei (Denver, USA) talks to BLearning at SNIS 2019 (22–25 July, Miami, USA) to discuss recent data from the cohort of thrombectomy trials which has shown...
Endovascular thrombectomy decision-making: Practice area and physician experience among top factors...
A survey investigating the factors associated with the decision-making for endovascular thrombectomy (EVT) procedures found that such decisions differed significantly between regions and specialities...
New study reveals independent predictors of the first-pass effect
Non-internal carotid artery (non-ICA) site of occlusion, the use of a balloon-guided catheter, and better collateral grade were all independent predictors of the first-pass...
Transradial access is safe and effective for neuroendovascular procedures
In the largest cohort study to date, new research from Jefferson (Philadelphia University and Thomas Jefferson University, Philadelphia, USA) demonstrates that transradial surgery, done...
Placebo-controlled RCTs of spinal cord stimulation are on the rise, but...
Important methodological aspects of clinical trials of spinal cord stimulation (SCS) using a placebo are consistently being poorly reported, says a recent systematic review....
SNIS 2019: Next-generation thrombectomy will be “even more powerful”
Matthew Gounis (Worcester, USA) talks to BLearning at SNIS 2019 (22–25 July, Miami, USA) about the current state of ischaemic stroke therapy. Gounis notes that...
SNIS 2019: Large scale endovascular treatment has improved outcomes for patients...
Andrew Molyneux (Oxford, UK) spoke to BLearning following his luminary lecture at SNIS 2019 (22–25 July, Miami, USA) titled, "Reflections on 30 years of cerebral...
SNIS 2019: In select patients, conventional imaging is “unnecessary” and they...
Marc Ribo (Barcelona, Spain) talks to BLearning at SNIS 2019 (22—25 July, Miami, USA) about the benefits of optimising time to thrombectomy by cutting out...
Stimwave announces completion of enrolment for the Tsunami placebo-controlled double-blind randomised...
Stimwave has announced completion of patient enrolment and preliminary results of the first-of-its-kind Tsunami study. The Tsunami placebo-controlled double-blind randomised clinical trial (RCT) is...
Medtronic partners with Viz.ai to accelerate adoption of new AI software
Medtronic and Viz.ai have partnered to accelerate the adoption of Viz.ai’s new technology, which helps synchronise stroke care and decrease time to treatment, potentially...
A stroke trial update from SNIS 2019
From tPA augmentation and stroke systems of care through to the rise of neuroprotective investigations, Santiago Ortega-Gutiérrez, University of Iowa (Iowa City, USA) kick...
Penumbra introduces latest stroke thrombectomy aspiration technology at SNIS 2019
Penumbra announces commercial availability of the Penumbra JET 7 reperfusion catheter with XTRA FLEX technology, at the Society of NeuroInterventional Surgery (SNIS) 16th Annual...
Corindus announces regulatory approval of CorPath GRX for neurovascular intervention in...
Corindus Vascular Robotics has announced that it received approval from the Australian Therapeutic Goods Administration to commercialise its CorPath GRX System for neurovascular interventions...
Perfusion-weighted parameter is “outstanding” at detecting penumbral flow in acute stroke
The performance of the best perfusion-weighted measure—time-to-maximum—to detect the upper penumbral flow threshold in ischaemic stroke has been deemed “outstanding” by the study investigators....
The “neurosurgical robot” facilitates further research in deep brain stimulation
The application of robot-assisted lead implantation in nonhuman primate neuromodulation research has been deemed feasible, accurate, safe and efficient in a recent study published...
Adam Arthur
Adam Arthur was one of few neurosurgeons in the USA to develop a busy practice in both open cerebrovascular surgery and endovascular neurosurgery. As...
NIH study to utilise NeuroPace RNS system for research on the...
NeuroPace has announced that the company’s RNS system, a closed-loop neuromodulation technology approved to treat adults with medically refractory focal onset epilepsy, will be...
Physicians’ Education Resource releases agenda for the 1st Annual International Congress...
Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), announces the full agenda for the 1st Annual International Congress on...
The first non-invasive, adaptive neuromodulation digital treatment for migraine receives CE...
Neurolief, a developer of digital therapeutics brain neuromodulation technology, has announced that it has received the CE mark for its Relivion non-invasive, adaptive digital treatment...
EVER Pharma launches patient friendly subcutaneous pump for Parkinson’s disease
EVER Pharma, a company specialising in neurological diseases, announces the launch of its D-mine Pump. This portable micro infusion device recently received European CE...
Latest FDA caution for the use of off-label drugs in intrathecal...
While the US Food and Drug Administration (FDA) has called for caution regarding the use of off-label medications administered intrathecally, pain management experts have...
Big data set to increase the efficiency of stroke outcomes research
A topical review published in Stroke investigates new approaches for the collection of outcomes data after stroke. In the context of global technological growth,...
Saluda Medical raises US$75 million equity financing from Boston Scientific and...
Following the announcement of the debt financing with Medtronic, Saluda Medical has announced that it has secured US$75 million in equity financing from Boston...
NeuroNews Issue 34 – US Edition
Highlights:
Big data is set to increase the efficiency of stroke outcomes research
Within the era of evolving technologies, Padma Gulur discusses cybersecurity, urging...
NeuroNews Issue 34
Highlights:
Big data is set to increase the efficiency of stroke outcomes research
Within the era of evolving technologies, Padma Gulur discusses cybersecurity, urging...
Neurotechnology holds promise for chronic stroke patients
Personalised neurotechnology-aided rehabilitation of the arm could improve recovery in severe chronic stroke patients according to a new paper published in the journal Brain.
Neurotechnology-based...
New published data affirms BrainsWay’s deep TMS system for the treatment...
BrainsWay has announced new data from an article published in the lastest issue of the American Journal of Psychiatry demonstrating that its deep TMS (dTMS) system...
Saluda Medical secures debt financing from Medtronic
Saluda Medical has announced that it has secured a four-year term loan agreement with Medtronic, to fund continued development of its Evoke ECAP-controlled, closed-loop...
Axonics announces FDA approval for the use of full-body MRI for...
Axonics have announced that the Food & Drug Administration (FDA) approved the use of full-body magnetic resonance imaging (MRI) using 1.5 Tesla MRI scanners...
Canon Medical receives FDA clearance for deep convolutional neural network image...
Building on its advanced image reconstruction technologies, Canon Medical Systems USA has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
Antiplatelet therapy shows “reassuring effects” on the risk of recurrent intracerebral...
“Starting antiplatelet therapy after intracerebral haemorrhage associated with antithrombotic drug use demonstrated reassuring effects on the risk of recurrent haemorrhage,” said Rustam Al-Shahi Salman...
Cybersecurity: Providers and patients beware
Within the context of evolving technologies that continue to expand healthcare connectivity, Padma Gulur warns of the “immense vulnerability of current systems”. Arguing that...
“Pain insensitive patient” may pave the way for new treatments of...
A recent study investigating a rare genetic mutation in a patient who “feels no pain” has suggested new routes to developing gene-therapy based analgesics...
New AI tool for detecting cerebral aneurysms enhances clinicians’ accuracy
Through developing a deep learning model to automatically detect clinically significant intracranial aneurysms on computed tomography (CT) angiography, clinicians’ sensitivity, accuracy, and interrater reliability...
Committed to neurovascular excellence by advancing stroke therapies
With the treatment paradigm for stroke continuing to evolve, meaningful innovation relies on advancing both stroke products and services. Through Stryker’s Stroke Knowledge Initiatives...
Advancing deep brain stimulation therapy for a fuller life
The evolution of directional leads to utilise deep brain stimulation (DBS) therapy has accelerated as the challenges with conventional (omnidirectional) DBS have been brought...
Bart van der Worp
President of the European Stroke Organisation (ESO) Bart van der Worp emphasises the need for additional treatment options for patients with acute ischaemic stroke,...
Medication-free treatment for depression launches in the UK
Flow launches a medication-free treatment for depression comprising a brain stimulation headset and therapy app. In Europe, Flow is classified as a Class IIa...
APERIO hybrid thrombectomy device receives CE mark approval
Acandis GmbH announces that it has received European CE mark approval for its APERIO hybrid thrombectomy device. APERIO is intended for restoration of the...
RAPID imaging platform expands options for speedy stroke treatment at Atlantic...
Recognising how vital it is that stroke neurosurgeons and neurologists receive timely information about the type of stroke a person is having so they...
Alteplase at 0.6mg/kg for stroke with unknown time of onset is...
Although an acceptable safety profile was demonstrated for MRI-guided thrombolysis with alteplase at 0.6mg/kg for stroke with unknown time of onset, the latter approach...
Combining contact aspiration with stent retriever techniques elicits no superiority
The first randomised controlled trial (RCT) to directly compare the efficacy of the combined use of contact aspiration and stent retriever against a stent...
The “overwhelming” efficacy of mechanical thrombectomy pursues in developing countries: RESILIENT,...
The final results of the first thrombectomy trial in a developing country convey the “overwhelming efficacy of mechanical thrombectomy”. Given that 35% of the...
Vesalio obtains additional CE approval for new products with NeVa clinical...
Vesalio has announced that it has obtained its second CE approval spanning multiple new NeVa product designs and technology. The new generation NeVa devices...
Saluda Medical announce three-month, 12-month and 18-month data on the Evoke...
Saluda Medical has announced that new data from multiple studies evaluating the company's Evoke ECAP-controlled, closed-loop spinal cord stimulation (SCS) system will be featured...
Key findings from a review of the indications, complications, and incidence...
A retrospective database review of 12,297 spinal cord stimulator (SCS) patients outlines key findings concerning the indications, incidence of minor and major complications, and...
Ambulance administration of transdermal glyceryl trinitrate does not improve outcomes in...
A study in which ambulance paramedics treated patients suspected of having an acute stroke with transdermal glyceryl trinitrate (GTN) to lower their blood pressure...
Vesalio secures US$5 million investment capital funding
Vesalio announces it has recently raised US$5 million in funding. The capital will support the continued global expansion of the NeVa Neurothrombectomy System, finance...
Abbott partners with NIH on BRAIN initiative to advance research for...
Abbott have announced that it has partnered with the National Institutes of Health (NIH) on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative...
Balt USA announces CE mark obtained for Titan aspiration catheter
Balt USA has announced that it has obtained CE mark for the Titan aspiration catheter. The Titan catheter line consists of a highly navigable,...
Burst stimulation of the spinal cord leads to greater pain modulation...
Data from a substudy of SUNBURST suggest that burst stimulation of the spinal cord regulates the medial pain pathway to a greater extent than...
The WEB-IT trial: Positive safety and effectiveness results announced
MicroVention has announced the publication of the WEB-IT pivotal trial results in the online edition of the Journal of NeuroInterventional Surgery.
The WEB aneurysm embolisation system...
Interdisciplinary approach to in-hospital stroke improves detection and treatment time
A recent study found that revision of an existing in-hospital stroke (IHS) protocol was associated with a lower rate of stroke mimics, and shorter...
NeuroPace present positive data from studies of the RNS System
NeuroPace has presented long-term clinical results demonstrating that the RNS System for refractory epilepsy significantly reduces seizure frequency in patients, with one in three...
Neuromod prepares for global commercialisation of Lenire tinnitus treatment
Neuromod Devices, the Irish medical technology company specialising in non-invasive neuromodulation technologies, has provided an update on organisational and leadership growth in preparation for...
Medtronic’s Evolve workflow with spinal cord stimulation demonstrates effective pain relief...
Medtronic has announced primary endpoint (three-month) results of the Vectors post-market clinical study that demonstrated effective pain relief and improved function in patients with...
“A failure in SCS is not a failure of the therapy...
Defining true success as “being able to decrease or even eliminate a patient’s dependency on oral opioids”, Corey W Hunter, founder of Ainsworth Institute...
Medtronic launches Solitaire X Revascularisation Device in the US
Medtronic has announced the US launch of the Solitaire X Revascularisation Device, and its first use in patients for the treatment of acute ischaemic...
Imperative Care announce US clearance of its ZOOM aspiration system
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of the company’s ZOOM aspiration system—a family of products designed to facilitate...
Many stroke patients not screened for osteoporosis, despite known risks
The majority of stroke survivors are not screened or treated for osteoporosis, broken bones, or fall risk—despite stroke being a risk factor for these...
Review shows inaccuracies of deep brain stimulation data for minimally conscious...
Results from a systematic review reveal that evidence for the use of deep brain stimulation (DBS) of various targets to promote recovery in patients...
Multicentre dataset reveals the added value of diffusion-weighted imaging to reduce...
Novel data from the Stroke from Thoracic Endovascular Repair (STEP) collaborators has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and...
International Neuromodulation Society announces 14th World Congress
The International Neuromodulation Society (INS) will hold its 14th World Congress from May 25–30, 2019 in Sydney, Australia. The multidisciplinary meeting highlights top international...
Study of SPR Therapeutics’ peripheral nerve stimulation system demonstrates sustained relief...
SPR Therapeutics have announced the study results of its SPRINT peripheral nerve stimulation (PNS) system in the treatment of post-amputation pain.
The study demonstrated that...
Welkin Health announces partnership to implement a programme to support commercialisation...
Welkin Health, a privately-held patient relationship management software company has announced that it is partnering with Axonics, a company focused on the design, development,...
Stimwave announces publication of 10 kHz Freedom Stimulator SURF RCT results
Stimwave has announced publication of the results of the first ever randomised, controlled trial (RCT) comparing wireless high-frequency (HF: 10 kHz) spinal cord stimulation...
Insera earns CE mark approval for cyclical-suction stroke thrombectomy platform, the...
Insera Therapeutics has announced that it has received CE mark approval for its flagship product, the CLEAR Aspiration System, for the aspiration of blood...
Vesalio reports expansion of international distributor network and Stroke Congress Exhibition...
Vesalio has announced that it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market...
Cost analysis concludes that the direct cost of stroke, at US$35...
The direct cost of stroke that currently stands at around US$35 billion dollars annually represents only the tip of the iceberg. Unemployment, missed work...
The blood pressure paradox in acute ischaemic stroke “lies in the...
The relationship between blood pressure and outcomes is highly dependent on reperfusion, conclude Lang Hong (Fudan University, Shanghai, China) and colleagues on behalf of...
New data show the therapeutic benefits of directional leads for use...
The PROGRESS study has achieved its primary endpoint and demonstrated superiority of the therapeutic window using Abbott directional stimulation compared to omnidirectional stimulation. Results...
Novel differential-target multiplexed technique outperforms conventional SCS
Continuous differential-target multiplexed (DTM) spinal cord stimulation (SCS) provides better thermal and mechanically induced pain relief compared to high-rate and low-rate SCS, concluded Ricardo...
Intensive blood pressure lowering beyond recommendations safely reduced the risk of...
Although intensive blood pressure lowering with intravenous thrombolysis is safe in patients with acute ischaemic stroke, the observed reduction in intracranial haemorrhage did not...
Is neurophysiology required for optimal deep brain stimulation targeting?
Acknowledging the lack of randomised data comparing the outcomes of “awake” versus “asleep” deep brain stimulation (DBS), Kim Burchiel (Oregon Health and Science University,...
Laboratory evaluation of a robotic operative microscope: A visualisation platform for...
Operative microscopes have become fundamental to the success of modern neurosurgical and other surgical specialty procedures. They have become active platforms for the development...
Physicians’ Education Resource to host first annual International Congress on the...
Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...
Less-invasive procedure helps surgeons pinpoint epilepsy surgical candidates
A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better...
Balt announces receiving CE marks for Ballast .088 Long Sheath
Balt International has announced receiving the CE mark for the Ballast .088 Long Sheath. The Ballast .088 Long sheath is indicated for the introduction...
Artificial Intelligence in prehospital stroke detection: Automation in motion
Acknowledging the current limitations that hinder optimal stroke screening in the prehospital setting, Mark McDonald (University of Virginia, Charlottesville, USA), one of the co-founders...
Evoke: The first RCT to measure spinal cord activations in response...
The protocol design for a multicentre, prospective, randomised, double-blind study comparing ECAP- (evoked compound action potential) controlled closed-looped with open-loop, fixed output spinal cord...
Reperfusion promotes favourable outcomes in ischaemic stroke patients with ASPECTS 0–5...
In a subgroup of acute ischaemic stroke patients presenting with Alberta stroke program early CT score (ASPECTS) 0–5, who were treated with mechanical thrombectomy,...
NeuroNews Issue 33 – US Edition
Highlights:
MISTIE III endpoint is missed, but experts agree on implications for clinical practice
Mark McDonald discusses the role of artificial intelligence in prehospital...
NeuroNews Issue 33
Highlights:
MISTIE III endpoint is missed, but experts agree on implications for clinical practice
Mark McDonald discusses the role of artificial intelligence in prehospital...
Medtronic announces FDA clearance and US launch of the Accurian RF...
Medtronic has announced US Food and Drug Administration (FDA) 510(k) clearance of the Accurian RF ablation platform, which conducts radio frequency (RF) ablation of...
Artis icono from Siemens Healthineers expands precision with improved visualisation in...
At the European Congress of Radiology (ECR; 27 February–3 March, Vienna, Austria) Siemens Healthineers will introduce the Artis icono biplane, an angiography system with...
Positive results for the treatment of medication-resistant epilepsy using Neuroelectrics’ Starstim
At the recent American Epilepsy Society Annual Meeting in New Orleans, USA, Neuroelectrics presented positive results from its clinical trial treating patients with drug...
CMS trial clearance for LivaNova’s vagus nerve stimulation therapy for treatment-resistant...
LivaNova has recognised that the US Centers for Medicare & Medicaid Services (CMS) finalised its National Coverage Determination (NCD) for the LivaNova vagus nerve...
Axonics granted full-body MR-conditional CE mark for its sacral neuromodulation system
Axonics has announced that it has received CE mark approval for 1.5T and 3T full-body magnetic resonance imaging conditional labelling for the Axonics r-SNM...
iSchemaView’s RAPID approved for use in Brazil
iSchemaView receives approval from ANVISA (the Brazilian Health Regulatory Agency), for the use of the RAPID imaging platform across Brazil.
RAPID is designed to...
Stimwave address patent infringement lawsuit brought by Nevro
Stimwave issued a statement today in response to a complaint made by Nevro in Federal Court Delaware District last week alleging Stimwave is infringing...
Real-world review reports significant reduction in pain with high-frequency 10kHz SCS
A multicentre real-world review of 10kHz of spinal cord stimulation (SCS) for the treatment of chronic back and leg pain has elicited positive results,...
The efficacy of endovascular stroke therapy outside of specialised centres needs...
Real-world data investigating patient outcome after endovascular stroke therapy in high versus low volume centres finds a 30% increase in the likelihood of a...
Medtronic’s deep brain stimulation for medically-refractory epilepsy launches in the USA
Medtronic has announced both the US launch of deep brain stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted patient at Emory University...
Axonics announce positive clinical data from its ARTISAN sacral neuromodulation pivotal...
Axonics has disclosed positive top-line results from the ARTISAN-SNM pivotal study, designed to gain marketing approval from the US Food and Drug Administration (FDA)...
Nevro files lawsuit for patent infringement against Stimwave
Nevro has announced that it has filed a lawsuit for patent infringement against Stimwave Technologies. The lawsuit, filed in the United States District Court...
Presented at the ISC: PHAST-TSC trial for treatment of acute stroke
Following the American Heart Association’s International Stroke Conference (ISC; 5–8 February, Hawaii, USA), Diffusion Pharmaceuticals announce a poster presented at the conference, outlining the...
Corindus announces FDA submission for neurovascular intervention indication for CorPath GRX
Corindus Vascular Robotics announces that it is seeking premarket clearance from the US Food and Drug Administration (FDA) to use the CorPath GRX System...
NeuroPace announces new Category I CPT code for the RNS system
NeuroPace has announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT) code for electrocorticography from an implanted...
Neurologists speak out about gender disparity at global stroke gathering
The International Stroke Conference (ISC) attracts thousands of neurologists each year to network with fellow experts and watch compelling presentations on the very latest...
CT perfusion core volume and time found strongly associated with EVT...
The likelihood of good clinical and safety outcomes after endovascular thrombectomy in patients with large core on CT ASPECTS (Alberta stroke programme early CT...
Todd Sitzman
Todd Sitzman is the medical director of Advanced Pain Therapy at a comprehensive pain clinic in Hattiesburg, Mississippi. As president of the North American...
Standard treatment of hyperglycaemia in acute ischaemic stroke outperforms an intensive...
Intensive glucose control (80–130mg/dL) does not improve 90-day functional outcome and increases the risk of severe hypoglycaemia. This is the conclusion presented by Karen...
FDA approval on expanded indication for Pipeline Flex embolisation device
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval on an expanded indication for its Pipeline Flex embolisation device. Previously...
Patrick Lyden receives eminent American Stroke Association Award
Patrick D Lyden, a world-renowned stroke expert who played a key role in the pivotal clinical trial leading to approval of the first proven...
Acute ischaemic stroke care continuum: With stroke patients every step of...
This video has been sponsored by Medtronic
With the treatment paradigm for stroke still evolving and the community committed to discovering and implementing the most...
Are drug-coated balloons and drug-eluting stents the future in intracranial atherosclerotic...
Alternative treatment options for patients with intracranial atherosclerotic disease (ICAD) are needed, given its prevalence worldwide and the associated risk of recurrent ischaemic events....
From a primary to a comprehensive stroke centre: steps to success...
Advertorial
In 2008, St Mary’s Medical Center and the Palm Beach Children's Hospital in West Palm Beach, Florida USA, initiated an ambitious transition from a...
Spectra WaveWriter spinal cord stimulator system launches in Europe
The launch of the Spectra WaveWriter spinal cord stimulator (SCS; Boston Scientific) system in Europe has been announced. The Spectra WaveWriter SCS system is...
iSchemaView and NeuroLogica team up to mobilise stroke care worldwide
iSchemaView and NeuroLogica have announced a partnership to integrate iSchemaView’s RAPID cerebrovascular imaging platform with NeuroLogica’s portable CereTom computed tomography (CT) scanners for use...
Abbott receives CE mark of MR-conditional labelling for Infinity deep brain...
Parkinson’s disease, dystonia and essential tremor patients in CE Mark countries will now benefit from upgraded functionality and new magnetic resonance (MR) conditional labelling...
Imperative Care announces FDA clearance of initial products
Imperative Care have announced US Food and Drug Administration (FDA) 510(k) clearance of its first family of access catheters, designed to deliver interventional treatments...
The future of neurostimulation: Smart neuromodulation
Better understanding of the brain alongside the integration of artificial intelligence may represent the future of neuromodulation. From machine learning and novel technology to...
Study finds significant reduction in pain with high-frequency 10kHz peripheral nerve...
A randomised controlled trial (RCT) of peripheral nerve stimulation (PNS) at 10kHz frequency demonstrates a significant reduction in pain scores for patients suffering from...
Going beyond DAWN and DEFUSE 3: New studies point to need...
A series of studies published in the Journal of NeuroInterventional Surgery is bringing attention to potential constraints in the practice-changing DAWN and DEFUSE 3 trials, when...
FDA clears RAPID imaging platform for use in selecting acute stroke...
iSchemaView has announced that the US Food and Drug Administration (FDA) has cleared the RAPID neuroimaging platform for use in selecting stroke patients who...
Perflow Medical expands IP coverage for Stream and Cascade devices
Perflow Medical has announced the issuance of four international patents that expand the global intellectual property (IP) coverage for the novel Stream Dynamic Neuro-Thrombectomy...
Majority of radiculopathy patients prefer burst to conventional tonic stimulation
BurstDR stimulation confers a greater reduction in leg and back pain intensity on patients with failed back surgery syndrome that tonic stimulation does, a...
RACECAT trial comparing transfer of acute stroke patients enrols 715 patients
The preliminary results of the RACECAT trial—a study comparing transfer of acute stroke patients with suspected large vessel occlusion (LVO) to the closest local...
The top 10 takeaways from “The Neuromodulation Appropriateness Consensus Committee on...
In 2018, the International Neuromodulation Society (INS) project on Consensus Conferences published “The Neuromodulation Appropriateness Consensus Committee on Best Practices for Dorsal Root Ganglion...
Novel intrasaccular aneurysm treatment device receives FDA PMA approval
MicroVention has announced that the FDA premarket approval (PMA) for the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms....
Companies partner for a non-invasive neuromodulation device to treat spasticity
WeHealth by Servier, the e-health department of Servier Group, and PathMaker Neurosystems, have announced the closing of a partnership agreement to develop and commercialise...
InspireMD report “superior clinical outcomes” for next-generation mesh-covered stents
InspireMD has released the results of a meta-analysis of four clinical studies involving dual-layered and mesh-covered stents, including the company’s MicroNet-covered stent, the CGuard...
FDA approves Smart Programmer for the InterStim system
Medtronic has announced the US Food and Drug Administration (FDA) approval of the InterStim smart programmer for use with the InterStim system, which provides...
FDA approval of Exablate Neuro for the treatment of tremor-dominant Parkinson’s...
InSightec has announced that The Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has approved an expansion...
Percutaneous PNS may hold the potential to shift the chronic pain...
A recent study demonstrates the potential value of percutaneous peripheral nerve stimulation (PNS) for chronic low back pain. Data reported by Christopher A. Gilmore...
Favourable revascularisation rates for first-in-man results of the Versi Retriever in...
First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...
Nuvectra receives full-body MR-conditional CE Mark approval for Algovita
Nuvectra has announced that it has received full-body MR-conditional approval for the Company’s Algovita spinal cord stimulation (SCS) system from its European Notified Body,...
Cerenovus launches largest global registry to study stroke-inducing blood clots removed...
Johnson & Johnson has announced that its Cerenovus business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyse stroke-inducing...
Nuvectra receives FDA head-only MR-conditional approval for Algovita
Nuvectra has announced that it has received US Food and Drug Administration (FDA) head-only MR-conditional approval for the company’s Algovita spinal cord stimulation (SCS) system.
Scott...
InSightec receives CE Mark for Exablate Neuro for Siemens Healthineers MRI...
New magnetic resonance imaging (MRI) compatibility holds potential to expand patient access around the world to incisionless brain surgery. Siemens Healthineers and InSightec have...
Medical attention seeking for TIAs and minor stroke after the ‘Act...
Standing in stark contrast to the public’s response to major stroke, the extensive FAST-based public education campaign has not improved the response to transient...
Good news for gamblers: Transcranial direct current stimulation found to enhance...
Transcranial direct current stimulation (tDCS) offers a novel intervention for individuals with gambling disorder, concluded a recent study that found that its use enhanced...
The evolving role of telemedicine in acute stroke treatment
Amid the current modernisation of ischaemic stroke treatment, Michael Chen discusses how telemedicine not only has tremendous value, but should become a more standard...
Positive results published on the acute treatment of migraine using the...
Cephalalgia, the official peer-reviewed medical journal of the International Headache Society, has published positive results of the American multicentric clinical trial ACME (Acute migraine...
Mainstay Medical announces headline results from ReActiv8-B clinical study
Mainstay Medical International, a medical device company focused on commercialising ReActiv8, an implantable restorative neurostimulation system designed to treat an underlying cause of disabling...
Viz.ai and NICO announce collaboration to speed patient recruitment in the...
Viz.ai and NICO have announced a collaboration to incorporate a new innovative clinical trial recruitment software from Viz.ai into the seminal ENRICH study which...
New approvals allow chronic pain sufferers to try Abbott’s non-opioid pain...
Abbott has announced the launch of the new dorsal root ganglion (DRG) Invisible Trial System, which is approved by the US Food and Drug...
New results demonstrate ability to automatically detect suspected large-vessel occlusion stroke...
Viz.ai has further advanced the field of stroke imaging and workflow by developing a novel method for the detection of signs of large vessel...
Viz.ai designated as American Heart Association/American Stroke Association Get With the...
Viz.ai, an applied artificial intelligence company, has been designated as a compatible vendor for the American Heart Association/American Stroke Association Get With The Guidelines...
iSchemaView RAPID integrates with Join, Allm’s medical communications platform
iSchemaView has announced that the RAPID platform is now compatible with Join, a medical communication app developed by Allm, a multinational developer of mobile...
First use of SPRINT endura peripheral nerve stimulation system to treat...
SPR Therapeutics has announced that Marc Huntoon, director of pain management at the Neuroscience, Orthopaedic and Wellness Center, VCU Medical Center, was the first...
First patients enrolled in CERUS study to treat intracranial aneurysms using...
Cerus Endovascular has announced enrolment of the first patients in the CERUS study (Contour Neurovascular System European Pre-Market Unruptured Aneurysm Study). The CERUS study...
New data shows positive outcomes for the NeuroBlate laser system for...
Monteris Medical, a company specialising in minimally invasive, image-guided laser ablation systems, has announced that the favourable results of its Laser ablation after stereotactic...
Canadian-led international study shows huge costs of delayed access to stroke...
It has been known for years that it is important to get stroke patient’s treatment as soon as possible to increase their chances of...
Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...
Stimwave Technologies has announced that it has received US Food and Drug Administration (FDA) clearance for the WaveCrest Mobile iOS platform patient controllers for...
New nanomaterial could enable early detection and diagnosis of Alzheimer’s disease
Researchers from Hong Kong Baptist University (HKBU) have discovered a new nanomaterial which could enable the early detection and diagnosis of Alzheimer’s disease.
The image...
FDA approves new SynchroMed II myPTM Personal Therapy Manager that enables...
Medtronic has announced US Food and Drug Administration (FDA) approval of the new SynchroMed II myPTM Personal Therapy Manager for patients with chronic pain....
Acandis receives European CE mark approval for its ACCERO stent
Acandis has announced that it has received European CE mark approval for its ACCERO stent, which is now available for sale in Europe. The...
Monteris Medical announces FDA clearance of NeuroBlate Optic laser probe
Monteris Medical has announced it has received clearance from the US Food and Drug Administration (FDA) for its NeuroBlate Optic laser probe, a laser...
Biogen advances research to improve outcomes for patients with multiple sclerosis
Through its research initiatives, Biogen aims to identify new ways to manage and monitor multiple sclerosis (MS) disease progression and provide physicians with...
Medtronic launches the Control Workflow to help eliminate oral opioids and...
Medtronic has announced the US launch of the Control Workflow, an evidence-based approach for use with the SynchroMed II intrathecal drug delivery system ("Medtronic...
NeuroNews Issue 31 – US Edition
In this issue:
SCENT trial leads to first ever indication of flow diverter to treat challenging aneurysms
Evidence in favour of DRG stimulation builds...
NeuroNews Issue 31
In this issue:
SCENT trial leads to first ever indication of flow diverter to treat challenging aneurysms
Evidence in favour of DRG stimulation builds...
SPR Therapeutics awarded US$10M to develop its SPRINT peripheral nerve stimulation...
SPR Therapeutics has been awarded two new grants and one new contract from the US Department of Defense totalling US$10M to further develop its...
First intracranial aneurysm patients treated with BRAVO Flow Diverter
Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...
SPR Therapeutics announces first use of SPRINT extensa dual-lead peripheral nerve...
SPR Therapeutics, a developer of neurostimulation technology for pain management, has announced that Christopher Gilmore of Carolinas Pain Institute was the first to use...
Largest ever study of depression and anxiety to transform mental health...
Researchers at King’s College London are launching the largest ever single study of depression and anxiety. By recruiting at least 40,000 people in England...
Vesalio initiates full commercial launch of NeVa
NeVa next-generation neurothrombectomy system
Vesalio has announced that it has initiated the full commercial European launch of its NeVa neurothrombectomy platform at the 10th annual...
Innovative on-ambulance PHAST-TSC trial for treatment of acute stroke approved by...
Diffusion Pharmaceuticals, a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where...
Phase 2 trial of novel treatment for ischaemic stroke initiated
Thrombolytic Science (TSI) has announced initiation of a phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of...
Greater obliteration and less in-stent stenosis after ATLAS stent coiling as...
According to research published in the Journal of NeuroIntervential Surgery, Atlas stent-assisted coiling outperformed LVIS Jr in terms of greater obliteration rates and lower...
